大动脉硬化与不确定潜力的克隆性血液形成之间的关联
Minkwan Kim1, Jin Ju Kim2, Seung-Tae Lee3
1Division of Cardiology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine and Cardiovascular Center, Yongin, Korea.
Annals of laboratory medicine
|January 11, 2024
概括
不确定潜力的克隆性血液形成 (CHIP) 与大动脉硬化 (AVS) 中较大的克隆有关. 这表明CHIP可能有助于AVS的发展,这需要进一步调查因果关系.
科学领域:
- 心血管医学 心血管医学
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
背景情况:
- 退行性大动脉膜疾病,包括大动脉狭窄,缺乏明确的机制和治疗目标.
- 大动脉硬化 (AVS) 是一种化的大动脉状况,没有显著的狭窄,其发展尚未完全理解.
研究的目的:
- 研究不确定潜力的克隆性血液形成 (CHIP) 与大动脉硬化症 (AVS) 的发展之间的关联.
主要方法:
- 招募了187名参与者 (125名AVS,62名对照) 年龄为72.6±8.5岁.
- 利用了24个CHIP基因的下一代测序.
- 进行逆概率治疗权重 (IPTW) 分析,以调整基线特征.
主要成果:
- 在AVS和对照组中,CHIP检测率 (VAF ≥0.5%) 在AVS和对照组之间相似.
- 与对照组相比,AVS组显示出明显更大的CHIP克隆 (VAF≥1%和≥2%).
- AVS独立地与VAF≥1% (aOR:2.44,95%CI:1.11-5.36) 相关.
结论:
- 患有AVS的个体比年龄和性别匹配的对照人群更频繁地表现出更大的CHIP克隆.
- 需要进一步的研究来确定AVS和CHIP之间的因果关系.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Production of Formed Elements
1.4K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.4K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
Overview of Hematopoiesis
4.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.0K


